Ljungberg B, Roos G, Toolanen G
University of Umeå, Sweden.
J Bone Joint Surg Br. 1990 Jan;72(1):111-5. doi: 10.1302/0301-620X.72B1.2298767.
The DNA content of the tumour cells in 10 patients with primary renal cell carcinomas was analysed; from six of the patients skeletal metastases were also studied. Four patients had homogenously diploid primary tumours, with solitary metastases. Six patients had aneuploid primary tumours, three with solitary and three with multiple metastases. In two patients radical excision of diploid metastases resulted in long disease-free intervals. Patients with diploid tumours survived significantly longer than patients with aneuploid tumours. These results indicate that tumour DNA content might be a useful prognostic indicator. The measurement of DNA content may be a suitable method of identifying those patients likely to survive long enough to benefit from major surgical resection and reconstruction.
分析了10例原发性肾细胞癌患者肿瘤细胞的DNA含量;其中6例患者的骨转移情况也进行了研究。4例患者的原发性肿瘤为均一的二倍体,伴有孤立性转移。6例患者的原发性肿瘤为非整倍体,3例伴有孤立性转移,3例伴有多发性转移。2例患者的二倍体转移灶根治性切除后出现了较长的无病间期。二倍体肿瘤患者的生存期明显长于非整倍体肿瘤患者。这些结果表明,肿瘤DNA含量可能是一个有用的预后指标。测量DNA含量可能是一种合适的方法,用于识别那些有可能存活足够长时间以从大型手术切除和重建中获益的患者。